EUVIMEDEUVIMED entdecken
Kohortenstudie

Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4‐RD patients: A retrospective cohort study over a decade

Yu Peng, Mu Wang, Ruijie Sun, Yuxue Nie iD, Nianyi Zhang, Xin He, Boyuan Sun, Linyi Peng iD, Yunyun Fei iD, Jiaxin Zhou iD, Mengtao Li iD, Wen Zhang iD

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.13814 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Yu Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical…. Hauptthemen laut MEDLINE: Recurrence, Immunoglobulin G, Immunoglobulin G4-Related Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Chinese National Key Technology R&D Program, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Our study aimed to investigate the distinct clinical patterns of seronegative IgG4‐related disease (IgG4‐RD) patients.

Methods

We retrospectively enrolled 698 treatment‐naïve IgG4‐RD patients in this study. Patients were divided into four different subgroups according to their baseline serum IgG4 levels. The distinct clinical patterns of seronegative IgG4‐RD patients were revealed through the comparison of baseline clinical data and disease prognosis among the different subgroups. COX regression analyses were used to investigate the risk factors for disease relapse and to construct the nomogram model.

Results

Seronegative IgG4‐RD patients account for a minority of IgG4‐RD patients (49/698, 7.02%). The proportions of seronegative IgG‐RD patients in our study and several Asian cohorts were significantly lower than those of the European and American cohorts. Seronegative IgG4‐RD patients got lower serum IgG levels ( p < 0.0001), lower eosinophil count ( p < 0.0001), lower serum IgE levels ( p < 0.0001)), lower IgG4‐RD responder index (RI) scores ( p < 0.0001), and fewer affected organ numbers ( p < 0.0001) compared with other subgroups, whereas they were more likely to manifest fibrotic type with some special organ involvement. Younger age at onset, GCs monotherapy, elevated C‐reactive protein level, and elevated erythrocyte sedimentation rate level are the risk factors for the disease relapse of seronegative IgG4‐RD patients. An effective nomogram model predicting disease relapse of seronegative IgG4‐RD patients was constructed. Seronegative IgG4‐RD patients with scores >84.65 at baseline were susceptible to suffering from disease relapse.

Conclusions

Distinct clinical features and multiple risk factors for disease relapse of seronegative IgG4‐RD patients have been revealed in this study. A nomogram model was constructed to effectively predict disease relapse during the follow‐up period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RecurrenceImmunoglobulin GImmunoglobulin G4-Related DiseaseHumansRetrospective StudiesMaleFemaleRisk FactorsMiddle AgedAdultAgedNomogramsPrognosis

Stichwörter der Autor:innen

clinical patternsdisease relapseprediction modelseronegative IgG4‐related disease

Substanzen

Immunoglobulin G

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
  • State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China.
  • Key Laboratory of Rheumatology and Clinical Immunology, The Ministry of Education, Beijing, China.
  • Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

ORCID-Profile: Yuxue Nie, Linyi Peng, Yunyun Fei, Jiaxin Zhou, Mengtao Li, Wen Zhang

Förderung

  • Chinese National Key Technology R&D Program
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences
  • PUMCH Science Fund for Young Scholars
  • National High Level Hospital Clinical Research Funding
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Peng, Y., Wang, M., Sun, R., Nie, Y., Zhang, N., He, X., Sun, B., Peng, L., Fei, Y., Zhou, J., Li, M., & Zhang, W. (2024). Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4‐RD patients: A retrospective cohort study over a decade. Journal of Internal Medicine. https://doi.org/10.1111/joim.13814

Vancouver

Peng Y, Wang M, Sun R, Nie Y, Zhang N, He X, et al. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4‐RD patients: A retrospective cohort study over a decade. Journal of Internal Medicine. 2024. doi:10.1111/joim.13814

BibTeX
@article{Peng2024,
  author = {Peng, Yu and Wang, Mu and Sun, Ruijie and Nie, Yuxue and Zhang, Nianyi and He, Xin and Sun, Boyuan and Peng, Linyi and Fei, Yunyun and Zhou, Jiaxin and Li, Mengtao and Zhang, Wen},
  title = {Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4‐RD patients: A retrospective cohort study over a decade},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.13814}
}
Kostenlos starten →